References
- 1. J. K. Slack-Davis, K. H. Martin, R. W. Tilghman, M. Iwanicki, E. J. Ung, C. Autry, M. J. Luzzio, B. Cooper, J. C. Kath, W. G. Roberts and J. T. Parsons, Cellular characterization of a novel focal adhesion kinase inhibitor, J. Biol. Chem. 282 (2007) 14845-14852; DOI: 10.1074/jbc.M606695200.
- 2. M. J. van Nimwegen and B. van der Water, Focal adhesion kinase: A potential target in cancer therapy, Biochem. Pharmacol. 73 (2007) 597-609; DOI: 10.1016/j.bcp.2006.08.011.
- 3. J. D. Hood and D. A. Cheresh, Role of integrins in cell invasion and migration, Nat. Rev. Cancer 2 (2002) 91-100; DOI: 10.1038/nrc727.
- 4. T. Miyazaki, H. Kato, M. Nakajima, M. Sohda, Y. Fukai, N. Masuda, R. Manda, M. Fukuchi, K. Tsukada and H. Kuwano, FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma, Br. J. Cancer 89 (2003) 140-145; DOI: 10.1038/sj.bjc.6601050.
- 5. J. T. Parsons, J. Slack-Davis, R. Tilghman and W. G. Roberts, Focal adhesion kinase: Targeting adhesion signaling pathways for therapeutic intervention, Clin. Cancer Res. 14 (2008) 627-632; DOI: 10.1158/1078-0432.CCR-07-2220.
- 6. J. M. Stiles, R. K. Rowntree, C. Amaya, D. Diaz, V. Kokta, D. C. Mitchell and A. B. Brad, Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells, Vasc. Cell 5 (2013) 1-12; DOI: 10.1186/2045-824X-5-6.
- 7. L. V. Owens, L. Xu, G. A. Dent, X. Yang, G. C. Sturge, R. J. Craven and W. G. Cance, Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer, Ann. Surg. Oncol. 3 (1996) 100-105; DOI: 10.1007/BF02409059.
- 8. D. D. Schlaepfer, C. R. Hauck and D. J. Sieg, Signaling through focal adhesion kinase, Prog. Biophys. Mol. Biol. 71 (1999) 435-478; DOI: 10.1016/S0079-6107(98)00052-2.
- 9. L. A. Cohen and J. L. Guan, Mechanisms of focal adhesion kinase regulation, Curr. Cancer Drug Tar. 5 (2005) 629-643; DOI: 10.2174/156800905774932798.
- 10. P. Mabeta and M. S. Pepper, Inhibition of hemangioma development in a syngeneic mouse model correlates with Bcl-2 suppression and the inhibition of Akt kinase activity, Angiogenesis 15 (2012) 131-139; DOI: 10.10007/s10456-011-9248-7.
- 11. H. P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit and N. Ferrara, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation, J. Biol. Chem. 273 (1998) 30336-30343; DOI: 10.1074/jbc.273.46.30336.
- 12. K. T. Sabapathy, M. S. Pepper, F. Kiefer, U. Möhle-Steinlein, F. Tacchini-Cottier, I. Fetka, G. Breier, W. Risau, P. Carmeliet, R. Montesano and E. F.Wagner, Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system, J. Cell Biol. 137 (1997) 953-963; DOI: 10.1083/jcb.137.4.953.
- 13. P. Mabeta and M. S. Pepper, Altered expression of platelet factor 4 and basic fibroblast growth factor correlates with the inhibition of tumor growth in mice, Biomed. Pharmacol. 69 (2015) 186-190; DOI: 10.1016/j.biopha.2014.11.018.
- 14. M. A. Cabrita, L. M. Jones, J. L. Quizi, L. A. Sabourin, B. C. McKay and C. L. Addison, Focal adhesion kinase inhibitors are potent anti-angiogenic agents, Mol. Oncol. 5 (2011) 517-526; DOI: 10.1016/ jmolonc.2011.10.004.
- 15. S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen, R. I. Nicholson and P. Barrett-Lee, Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells, Breast Cancer Res. Treat. 125 (2011) 659-669; DOI: 10.1007/s10549-010-0857-4.
- 16. P. W. Bryant, Q. Zheng and K. M. Pumiglia, Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells, Biol. Open 15 (2012) 723-730; DOI: 10.1242/ bio.20121008.
- 17. L. Portt, G. Norman, C. Clapp, M. Greenwood and M. T. Greenwood, Anti-apoptosis and cell survival: A review, Biochim. Biophys. Acta 1813 (2011) 238-259; DOI: 10.1016/j.bbamcr.2010.10.010.
- 18. X. Zhao and J. L. Guan, Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis, Adv. Drug Deliver. Rev. 63 (2011) 610-615; DOI: 10.1016/j.addr.2010.11.001.
- 19. S. K. Mitra, D. A. Hanson and D. D. Schlaepfer. Focal adhesion kinase: in command and control of cell motility, Nat. Rev. Mol. Cell Biol. 6 (2005) 56-68; DOI: 10.1038/nrm1549.
- 20. B. Tavora, S. Batista, L. Reynolds, S. Jadeja, S. Robinson, V. Kostourou, I. Hart, M. Fruttiger, M. Parsons and K. M. Hodivala-Dilke, Endothelial FAK is required for tumour angiogenesis, EMBO Mol. Med. 2 (2010) 516-528; DOI: 10.1002/emmm.201000106.
- 21. L. H. Xu, X. Yang, C. A. Bradham, D. A. Brenner, J. A. S. Baldwin, R. J. Craven and W. G. Cance, The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells, J. Biol. Chem. 275 (2000) 30597-30604; DOI: 10.1074/jbc. M910027199.
- 22. C. Wiza, E. B. M. Nascimento and D. M. Ouwens, Role of PRAS40 in Akt and mTOR signaling in health and disease, Am. J. Physiol. Endocrinol. Metab. 302 (2012) E1453-E1460; DOI: 10.1152/ajpendo.00660.2011.
- 23. H. Wang, Q. Zhang, Q. Wen, Y. Zheng, L. Philip, H. Jiang, J. Lin and W. Zheng, Proline-rich Akt substrate of 40 kDa (PRAS40): A novel downstream target of P13k/Akt signaling pathway, Cell Signal. 24 (2012) 17-24; DOI: 10.1016/j.cellsig.2011.08.010.
- 24. I. Ruvinsky, N. Sharon, T. Lerer, H. Cohen, M. Stolovich-Rain, T. Nir, Y. Dor, P. Zisman and O. Meyuhas, Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis, Genes Dev. 19 (2005) 2199-2211; DOI: 10.1101/gad.351605.
- 25. B. Gan, Y. Yoo and J. Guan, Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of S6 kinase activation and cell growth, J. Biol. Chem. 281 (2006) 37321-37329; DOI: 10.1074/jbc.M605241200.
- 26. A. Porras and C. Guerrero, Role of p38α in apoptosis: Implication in cancer development and therapy, Atlas Genet. Cytogenet. Oncol. Haematol. 15 (2011) 316-326; DOI: 10.4267/2042/44993.